SCHEMBL170631

SCHEMBL170631

CSCCCC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3302483 0.97
SCHEMBL3291670 0.92
SCHEMBL29311950 0.90 SOAT1 (0.43)
SCHEMBL11171034 0.90 SOAT1 (0.43)
SCHEMBL1478263 0.86
SCHEMBL25273914 0.79 FOLH1 (0.36)
SCHEMBL13374708 0.79 RECQL (0.42)
SCHEMBL154914 0.78
SCHEMBL2625079 0.78
SCHEMBL3078846 0.77 TSHR (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012031298-A2 ETHYNYLBENZENE DERIVATIVES DUKE UNIVERSITY (US) 2012-03-08 WO claimed
EP-1341755-A1 CARBOXYLIC ACID AMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF THROMBOEMBOLIC DISEASES AND TUMOURS MERCK PATENT GmbH (DE) 2003-09-10 EP claimed
EP-0874846-B1 PURINE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION NOVARTIS AG (CH) 2003-04-02 EP claimed
WO-2002048099-A1 CARBOXYLIC ACID AMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF THROMBOEMBOLIC DISEASES AND TUMOURS MERCK PATENT GMBH (DE) 2002-06-20 WO claimed
EP-0972066-A1 ENZYMATIC CONVERSION OF $g(a)-HYDROXYNITRILES TO THE CORRESPONDING $g(a)-HYDROXYAMIDES, ACIDS OR ACID SALTS Novus International, Inc. (US) 2000-01-19 EP claimed
WO-1998050031-A1 INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES UNIVERSITY OF PITTSBURGH (US) 1998-11-12 WO claimed
EP-0874846-A1 PURINE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION Novartis AG (CH) 1998-11-04 EP claimed
WO-1998032872-A1 ENZYMATIC CONVERSION OF α-HYDROXYNITRILES TO THE CORRESPONDING α-HYDROXYAMIDES, ACIDS OR ACID SALTS NOVUS INTERNATIONAL, INC. (US) 1998-07-30 WO claimed
WO-1997016452-A1 PURINE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION NOVARTIS AG (CH) 1997-05-09 WO claimed
EP-0577473-B1 Reducing cosmetic composition for the permanent deformation of hair based on a mercaptoalkylamino-amide and process for the permanent deformation of hair OREAL (FR) 1995-12-20 EP claimed
EP-0577473-A1 Reducing cosmetic composition for the permanent deformation of hair based on a mercaptoalkylamino-amide and process for the permanent deformation of hair L'OREAL (FR) 1994-01-05 EP claimed
US-4545985-A ANTICARCINOGENIC AGENTS THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) 1985-10-08 US claimed
EP-0057140-B1 THIOLATED POLYPEPTIDIC COMPOUND FROM A TETANIC TOXIN FRAGMENT, PROCESS FOR ITS PRODUCTION AND ITS APPLICATIONS INSTITUT PASTEUR (FR) 1985-07-17 EP claimed
EP-0030496-B1 THIOLATED POLYPEPTIDIC COMPOUND COMING FROM A FRAGMENT OF TETANIC TOXINE, PROCESS FOR OBTAINING IT AND ITS APPLICATIONS INSTITUT PASTEUR (FR) 1983-07-13 EP claimed
EP-0057140-A2 Thiolated polypeptidic compound from a tetanic toxin fragment, process for its production and its applications INSTITUT PASTEUR (FR) 1982-08-04 EP claimed
EP-0030496-A1 Thiolated polypeptidic compound coming from a fragment of tetanic toxine, process for obtaining it and its applications INSTITUT PASTEUR (FR) 1981-06-17 EP claimed
US-20240358710-A1 METHODS, COMPOSITIONS AND DEVICES FOR TREATING CANCER WITH ILLUDOFULVENES AF CHEMICALS, LLC (US) 2024-10-31 US disclosed
US-12023339-B2 Methods, compositions and devices for treating cancer with illudofulvenes AF CHEMICALS, LLC (US) 2024-07-02 US disclosed
EP-0057140-A2 Thiolated polypeptidic compound from a tetanic toxin fragment, process for its production and its applications INSTITUT PASTEUR (FR) 1982-08-04 EP disclosed
EP-0030496-A1 Thiolated polypeptidic compound coming from a fragment of tetanic toxine, process for obtaining it and its applications INSTITUT PASTEUR (FR) 1981-06-17 EP disclosed